Is there a kink in consumers' threshold value for cost-effectiveness in health care?

被引:105
|
作者
O'Brien, BJ
Gertsen, K
Willan, AR
Faulkner, LA
机构
[1] St Josephs Hosp, Ctr Evaluat Med, Hamilton, ON L8N 1G6, Canada
[2] Univ Nijmegen, Nijmegen, Netherlands
[3] McMaster Univ, Dept Clin Epidemiol & Biostat, Hamilton, ON, Canada
关键词
willingness to pay; willingness to accept; cost-effectiveness;
D O I
10.1002/hec.655
中图分类号
F [经济];
学科分类号
02 ;
摘要
Background: A reproducible observation is that Consumers' willingness-to-accept (WTA) monetary compensation to forgo a program is greater than their stated willingness-to-pay (WTP) for the same benefit. Several explanations exist, including the psychological principle that the utility of losses weighs heavier than gains. We sought to quantify the WTP-WTA disparity from published literature and explore implications for cost-effectiveness analysis accept-reject thresholds in the south-west quadrant of the cost-effectiveness plane (less effect, less cost)Methods: We reviewed published studies (health and non-health) to estimate the ratio of WTA to WTP for the same program benefit for each study and to determine if WTA is consistently greater than WTP in the literature. Results: WTA,WTP ratios were greater than unity for every study we reviewed. The ratios ranged from 3.2 to 89.4 for environmental studies (n = 7), 1.9 to 6.4 for health care studies (n = 2) 1.1 to 3.6 for safety studies (n = 4) and 13 to 2.6 for experimental studies (n = 7). Conclusions: Given that WTA is greater than WTP based on individual preferences, should not societal preferences used to determine cost-effectiveness thresholds reflect this disparity! Current convention in cost-effectiveness analysis is that any given accept-rejection criterion (e.g. $50 k/QALY gained) is symmetric - a straight line through the origin of the cost-effectiveness plane. The WTA-WTP evidence suggests a downward 'kink' through the origin for the south-west quadrant, such that the 'selling price' of a QALY is greater than the 'buying price'. The possibility of 'kinky cost-effectiveness' decision rules and the size of the kink merits further exploration. Copyright (C) 2002 John Wiley Sons, Ltd.
引用
收藏
页码:175 / 180
页数:6
相关论文
共 50 条
  • [41] The Value of Health in a Cost-Effectiveness Analysis: Theory Versus Practice
    Wouterse, Bram
    van Baal, Pieter
    Versteegh, Matthijs
    Brouwer, Werner
    PHARMACOECONOMICS, 2023, 41 (06) : 607 - 617
  • [42] The Value of Health in a Cost-Effectiveness Analysis: Theory Versus Practice
    Bram Wouterse
    Pieter van Baal
    Matthijs Versteegh
    Werner Brouwer
    PharmacoEconomics, 2023, 41 : 607 - 617
  • [43] COST-EFFECTIVENESS IN GERIATRIC CARE
    FARRINGTON, JF
    MINNESOTA MEDICINE, 1982, 65 (10) : 634 - 635
  • [44] Glaucoma Care Cost-Effectiveness
    Hoskins, H. Dunbar, Jr.
    OPHTHALMOLOGY, 2009, 116 (05) : 1016 - 1016
  • [45] Cost-effectiveness in wound care
    Nord, D
    ZENTRALBLATT FUR CHIRURGIE, 2006, 131 : S185 - S188
  • [46] Cost-effectiveness of psychiatric care
    Sharfstein, SS
    AMERICAN JOURNAL OF PSYCHIATRY, 1997, 154 (06): : 723 - 724
  • [47] Cost-effectiveness of hospice care
    Robinson, BE
    Pham, H
    CLINICS IN GERIATRIC MEDICINE, 1996, 12 (02) : 417 - &
  • [48] Standardizing cost-effectiveness analyses: The panel on cost-effectiveness in health and medicine
    Gold, MR
    ACADEMIC RADIOLOGY, 1998, 5 : S351 - S354
  • [49] Cost-effectiveness of Tuberculosis Screening in Health Care Workers Is Not Robust
    Mancuso, James
    Niebuhr, David
    Krauss, Margot R.
    Dabbs, Clifton
    Anderson, Katherine
    ARCHIVES OF INTERNAL MEDICINE, 2009, 169 (14) : 1336 - 1336
  • [50] Cost-effectiveness of transitional US plans for universal health care
    Galvani, Alison P.
    Fitzpatrick, Meagan C.
    LANCET, 2020, 395 (10238): : 1692 - 1693